Company CVAbout Bharat Parenterals Ltd 
Bharat Parenterals Ltd
Micro Cap
Pharmaceuticals & Drugs
Bharat Parenterals Ltd. was incorporated on Sep.'92 in Gujarat and promoted by Ramesh Desai and Bharat Desai. The Company is engaged in the business of manufacturing drugs, pharmaceutical formulations and ayurvedic products at its plant in Baroda. It has set-up a fully integrated and modern plant as per WHO standards at Haripura near Baroda for manufacturing pharmaceutical formulations, life saving drugs, parenterals and antibiotics.
Company Coordinates
Company Details
Survey No 144 & 146 Haripura, Jarod Samlaya Road Tal Savli Vadodara Gujarat : 391520
Registrar Details
Capital StructureCapital Structure
Present Equity Capital
INR 6.52 Cr
Number of Shares
65.24 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Jun-2024
65.24
6.52
704781
10
Preferential basis
12-Sep-2023
58.2
5.82
45000
10
Issued under ESOP Scheme
04-Jan-2022
57.75
5.77
45000
10
Issued under ESOP Scheme
21-Mar-2018
57.3
5.73
5729666
10
Allotment of Equity To Others
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 1 FIIs (0.11%)
Promoter with highest holding
Desai Shares And Stock Private Limited (39.63%)
Highest Public shareholder
Asoj Soft Caps Pvtltd(anchor) (4.94%)
Individual Investors Holdings
19.2%
Board of Directors
Management
Designation
Remuneration
Bharat Kumar R Desai
Managing Director
1.43 cr
Hemang Jayendrabhai Shah
Director
24.75 lacs
Shaileshkumar Ghabhawala
Director
10.0 k
Zankhana Sheth
Independent Director
10.0 k
Mukesh Patel
Independent Director
10.0 k
Sanjay Shah
Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Formulations
138.22
99.95%
Service Income - Jobwork
0.05
0.04%
Scrap
0.02
0.02%
Pharmaceutical Formulations
Pharmaceutical Formulations
Service Income - Jobwork
Service Income - Jobwork
Scrap
Scrap
Stock DNARevenue and Profits:
Net Sales:
72 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-2 Cr
Pharmaceuticals & Drugs
INR 682 Cr (Micro Cap)
NA (Loss Making)
33
0.10%
0.32
-0.97%
2.41
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
